← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Strategy Officer Sushil Patel sold $281K of Replimune Group, Inc.

Sold$281,129
$18.05Price
15,575Shares
−9%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, May 16. Filed Thu, May 18, 8:36 PM ET, after the close. Not investment advice.